These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10758300)

  • 41. The influence of L-arginine on biomechanical parameters of native and nonenzymatically glycated rat tail tendons.
    Reihsner R; Menzel EJ
    Connect Tissue Res; 1994; 31(1):55-65. PubMed ID: 15609622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skin tensile properties in patients treated for acromegaly.
    Braham C; Betea D; Piérard-Franchimont C; Beckers A; Piérard GE
    Dermatology; 2002; 204(4):325-9. PubMed ID: 12077539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased susceptibility of glycated very low density lipoproteins to lipoprotein lipase in vitro and prevention by glutathione.
    Saheki S; Shishino K; Hitsumoto Y; Murase M; Takeuchi N; Uchida K
    J Atheroscler Thromb; 1994; 1(1):8-14. PubMed ID: 9222863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renoprotective effects of a novel inhibitor of advanced glycation.
    Forbes JM; Soulis T; Thallas V; Panagiotopoulos S; Long DM; Vasan S; Wagle D; Jerums G; Cooper ME
    Diabetologia; 2001 Jan; 44(1):108-14. PubMed ID: 11206401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E; Soulis T; Boel E; Cooper ME; Rees S
    Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of non-enzymatic glycation on the micro- and nano-mechanics of articular cartilage.
    Moshtagh PR; Korthagen NM; van Rijen MHP; Castelein RM; Zadpoor AA; Weinans H
    J Mech Behav Biomed Mater; 2018 Jan; 77():551-556. PubMed ID: 29073574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperglycemia induced structural and functional changes in human serum albumin of diabetic patients: a physico-chemical study.
    Neelofar K; Arif Z; Alam K; Ahmad J
    Mol Biosyst; 2016 Jul; 12(8):2481-9. PubMed ID: 27226040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomechanical properties of dermis.
    Daly CH
    J Invest Dermatol; 1982 Jul; 79 Suppl 1():17s-20s. PubMed ID: 7086188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-enzymatic glycation in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro.
    McDermott AM; Xiao TL; Kern TS; Murphy CJ
    Optometry; 2003 Jul; 74(7):443-52. PubMed ID: 12877277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced glycation end products in diabetic corneas.
    Kaji Y; Usui T; Oshika T; Matsubara M; Yamashita H; Araie M; Murata T; Ishibashi T; Nagai R; Horiuchi S; Amano S
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):362-8. PubMed ID: 10670463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo.
    Doucet C; Huby T; Ruiz J; Chapman MJ; Thillet J
    Atherosclerosis; 1995 Nov; 118(1):135-43. PubMed ID: 8579623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reactivity of lecithin-cholesterol acyl transferase (LCAT) towards glycated high-density lipoproteins (HDL).
    Fournier N; Myara I; Atger V; Moatti N
    Clin Chim Acta; 1995 Jan; 234(1-2):47-61. PubMed ID: 7758222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes.
    Cartledge JJ; Eardley I; Morrison JF
    BJU Int; 2001 Mar; 87(4):402-7. PubMed ID: 11251537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study.
    Sannomiya P; Oliveira MA; Fortes ZB
    Br J Pharmacol; 1997 Nov; 122(5):894-8. PubMed ID: 9384505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aminoguanidine prevents peroxynitrite production and cardiac hypertrophy in streptozotocin-induced diabetic rats].
    Stadler K; Jenei V; Somogyi A; Jakus J
    Orv Hetil; 2004 Dec; 145(49):2491-6. PubMed ID: 15633737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The measurement and modelling of the mechanical properties of human skin in vivo--II. The model.
    Manschot JF; Brakkee AJ
    J Biomech; 1986; 19(7):517-21. PubMed ID: 3745224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of type I collagen gels modified by glycation.
    Francis-Sedlak ME; Uriel S; Larson JC; Greisler HP; Venerus DC; Brey EM
    Biomaterials; 2009 Mar; 30(9):1851-6. PubMed ID: 19111897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skin aging by glycation: lessons from the reconstructed skin model.
    Pageon H; Zucchi H; Rousset F; Monnier VM; Asselineau D
    Clin Chem Lab Med; 2014 Jan; 52(1):169-74. PubMed ID: 23770560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.